BioNexus Gene Lab Corp SEC filings BGLC

BioNexus Gene Lab Corp has 157 filings in SEC EDGAR's recent list, going back to Jan 29, 2019. Its latest annual report, Form 10-K, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Apr 14, 2026 Dec 31, 2025
10-K/A Amended annual report Apr 29, 2025 Dec 31, 2024
10-K Annual report Apr 15, 2025 Dec 31, 2024
10-K/A Amended annual report May 31, 2024 Dec 31, 2023
10-K/A Amended annual report May 31, 2024 Dec 31, 2022
10-K Annual report Apr 16, 2024 Dec 31, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K Annual report Apr 6, 2022 Dec 31, 2021
10-K Annual report Mar 30, 2021 Dec 31, 2020
10-K Annual report Mar 31, 2020 Dec 31, 2019

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
BGLC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
WY
Headquarters
Kuala Lumpur
SEC filer status
, Emerging growth company
SEC CIK
1737523
Former names
BioNexus Gene Lab Coporation (until May 8, 2020)

Other Services-Medical Laboratories companies

All 29 Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.